SUCLA2 and methylmalonic acidemia: In a Chinese study of 310 isolated methylmalonic acidemia patients, approximately 3.2% of patients were found to harbor a mutation in SUCLG1, while only 0.9% of them were secondary to the SUCLA2 mutation (5).